Td Asset Management Inc Biotechnology

Td Asset Management Inc

$108 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PHVS Pharvaris N.V.	$798M	$1.75 Million 0.0% of portfolio	99,510	Q2 2025 Added 27.38%
MRNA Moderna, Inc.	$10.8B	$1.71 Million 0.0% of portfolio	61,813	Q2 2025 Reduced 51.05%
IMTX Immatics N.V.	$835M	$1.55 Million 0.0% of portfolio	288,256	Q2 2025 Added 19.49%
JANX Janux Therapeutics, Inc.	$1.12B	$1.51 Million 0.0% of portfolio	65,236	Q2 2025 Reduced 0.61%
BCYC Bicycle Therapeutics PLC	$242M	$1.34 Million 0.0% of portfolio	193,092	Q1 2025 Reduced 10.61%
VRDN Viridian Therapeutics, Inc.\De	$960M	$1.25 Million 0.0% of portfolio	89,600	Q2 2025 Added 174.85%
WVE Wave Life Sciences Ltd.	$657M	$1.17 Million 0.0% of portfolio	179,608	Q2 2025 Added 16.32%
ADMA Adma Biologics, Inc.	$2.83B	$1.04 Million 0.0% of portfolio	56,852	Q2 2025 New
ACAD Acadia Pharmaceuticals Inc	$3.39B	$970,000 0.0% of portfolio	45,000	Q2 2025 New
BMRN Biomarin Pharmaceutical Inc	$10B	$947,000 0.0% of portfolio	17,241	Q2 2025 Reduced 50.91%
ALEC Alector, Inc.	$273M	$912,000 0.0% of portfolio	651,738	Q2 2025 Added 483.27%
SANA Sana Biotechnology, Inc.	$1.06B	$843,000 0.0% of portfolio	309,034	Q1 2025 Reduced 23.57%
ZLAB Zai Lab LTD	$2.81B	$843,000 0.0% of portfolio	24,128	Q2 2025 Reduced 91.84%
HRTX Heron Therapeutics, Inc.	$159M	$816,000 0.0% of portfolio	394,600	Q1 2025 New
XNCR Xencor Inc	$900M	$799,000 0.0% of portfolio	101,722	Q1 2025 Reduced 9.76%
GLUE Monte Rosa Therapeutics, Inc.	$461M	$776,000 0.0% of portfolio	172,078	Q1 2025 Reduced 21.82%
IDYA Ideaya Biosciences, Inc.	$1.47B	$736,000 0.0% of portfolio	35,036	Q1 2025 Reduced 46.34%
URGN Uro Gen Pharma Ltd.	$410M	$731,000 0.0% of portfolio	53,400	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$186M	$616,000 0.0% of portfolio	545,388	Q4 2024 Reduced 19.46%
NRIX Nurix Therapeutics, Inc.	$490M	$483,000 0.0% of portfolio	42,420	Q1 2025 Added 8.12%
AURA Aura Biosciences, Inc.	$175M	$432,000 0.0% of portfolio	69,030	Q4 2024 Added 14.99%
RCKT Rocket Pharmaceuticals, Inc.	$303M	$428,000 0.0% of portfolio	174,910	Q2 2025 Added 7.5%
BDTX Black Diamond Therapeutics, Inc.	$145M	$410,000 0.0% of portfolio	165,678	Q4 2024 Reduced 24.58%
ELYM Eliem Therapeutics, Inc.	$109M	$367,000 0.0% of portfolio	89,400	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$846M	$342,000 0.0% of portfolio	99,056	Q2 2025 Reduced 36.69%
ERAS Erasca, Inc.	$300M	$325,000 0.0% of portfolio	256,032	Q1 2025 Added 6.35%
TRDA Entrada Therapeutics, Inc.	$200M	$321,000 0.0% of portfolio	47,788	Q3 2024 Reduced 32.98%
IOVA Iovance Biotherapeutics, Inc.	$366M	$240,000 0.0% of portfolio	139,878	Q1 2025 Reduced 55.03%
VYGR Voyager Therapeutics, Inc.	$195M	$237,000 0.0% of portfolio	76,330	Q1 2025 Reduced 33.59%
ARVN Arvinas, Inc.	$517M	$168,000 0.0% of portfolio	22,878	Q2 2025 Reduced 77.55%
MRVI Maravai Lifesciences Holdings, Inc.	$463M	$155,000 0.0% of portfolio	64,658	Q2 2025 New
CABA Cabaletta Bio, Inc.	$79.5M	$134,000 0.0% of portfolio	88,600	Q3 2024 Reduced 33.9%
PRLD Prelude Therapeutics Inc	$50.6M	$130,000 0.0% of portfolio	160,652	Q3 2023 Added 100.0%
ANNX Annexon, Inc.	$150M	$112,000 0.0% of portfolio	46,848	Q1 2025 Reduced 64.95%
GBIO Generation Bio Co.	$368M	$109,000 0.0% of portfolio	340,686	Q4 2023 Reduced 16.21%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.